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Abstract

Background: The rate of colorectal cancer (CRC) screening in the United States
continues to be low, allowing colorectal cancers to remain undiagnosed and mortality
rates to remain high. Current literature points to lack of education, healthcare access, and
physician counseling as key barriers to screening, in addition to cognitive-emotional
apprehensions.

Objectives: This study examined whether cognitive-emotional apprehensions are barriers
to screening despite physician recommendation. Moreover, it examined what particular
cognitive-emotional barriers inhibit participation and how these barriers can potentially
be alleviated.

Methods: A convenience sample of 40 faculty members at Eastern Michigan University
were surveyed about attitudes toward screening.

Results: One half of non-screeners reported that cognitive-emotional apprehensions
limited their participation in screening tests. Predictors of adherence included concerns
about embarrassment or modesty, concerns about test preparation, fear of pain, and fear
of finding cancer.

Conclusions: Cognitive-emotional apprehensions are significant barriers to CRC
screening and may be improved by patient counseling.
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Chapter I: Introduction
Colorectal cancer (CRC) is a disease characterized by the uncontrolled growth
and proliferation of cells that form in the tissues of the colon and rectum, two segments
of the large intestine. It is the third most common form of cancer in the United States and
the second leading cause of cancer-related deaths. The National Cancer Institute (2008)
estimates that there will be 148,810 new cases and 49,960 deaths from colon and rectal
cancer in the United States in 2008. Thus, colorectal cancer is an especially prominent
and fatal disease in the country.
Although the causes of colorectal cancer are multifaceted, there are common
clinical features of the disease. The risk of developing colorectal cancer increases with
age; the peak incidence occurs in adults between 50 and 60 years old (Price & Wilson,
2003). The most common symptoms include a change in bowel habits, rectal bleeding or
blood in the stool, diarrhea or constipation, abdominal pain and distention, fatigue,
anemia, and weight loss. In some cases, however, colorectal cancer may present without
symptoms in people with no known history or predisposing factors; as a result, regular
surveillance is critical for the early detection of the disease.
Colorectal Cancer Screening
Colorectal cancer is highly detectable through regular screening programs.
Screening allows healthcare professionals to detect and remove precancerous polyps
before invasive cancer develops or to diagnose cancer early when treatment is most
effective. The Harvard Center for Cancer Prevention (1999) reports that regular
screening, combined with a healthy lifestyle, can prevent more than half of all colon
cancers in the United States. Moreover, according to the Centers for Disease Control and

Prevention (2007), the five-year relative survival rate is 90% when physicians diagnose
colorectal cancer at the early stages. Screening is therefore an important mechanism for
colorectal cancer prevention, detection, and survival.
There are several procedures for colorectal cancer surveillance, including the
fecal occult blood test (FOBT), double-contrast barium enema (DCBE), flexible
sigmoidoscopy, and colonoscopy. The FOBT checks for the presence of microscopic
amounts of blood in the stool, a potential symptom of colorectal cancer, by placing a
small sample of stool on a chemically treated card. In contrast, the DCBE test uses an
enema containing a barium dye and a series of x-rays to look for abnormalities in the
inner contours of the colon and rectum. The sigmoidoscopy and colonoscopy allow
physicians to examine the inside of the rectum or colon with a fiber-optic scope to look
for abnormal areas or growths; physicians may then remove samples of any abnormal
tissues for microscopic evaluation and diagnosis. Regardless of the test, the procedures
aim to detect precancerous polyps or localized carcinomas.
Although physicians are not in consensus on which screening tests should be used
or how often adults at average risk for cancer should be tested, all professional guidelines
emphasize the importance of regular surveillance. Price & Wilson (2003) note that, for
asymptomatic persons, men and women over 50 years of age should have a FOBT
annually and a sigmoidoscopy examination every three to five years. Similarly, the
American Cancer Society (2007) recommends that those people at average risk for cancer
and without any specific symptoms have a FOBT yearly, a flexible sigmoidoscopy or
DCBE every five years, or a colonoscopy every ten years, beginning at age 50. Persons
with a personal or family history of colorectal cancer should consider beginning
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screening earlier and/or undergoing screening procedures more frequently than the
guidelines recommend.
Statement of the Problem
Despite these guidelines, colorectal cancer screening rates continue to be low in
the United States. According to the Centers for Disease Control and Prevention (2006),
its 2000 National Health Interview Survey reveals that only 42.5% of adults age 50 or
older had a sigmoidoscopy or colonoscopy within the previous ten years or had a FOBT
within the preceding year. As a direct result, physicians detect less than 40% of
colorectal cancers early, which means that as many as 60% of colorectal cancer deaths
could be prevented if screening rates increased (Centers for Disease Control and
Prevention, 2006). It is therefore important to understand the factors contributing to low
screening adherence to prevent mortality from colorectal cancer in the future.
Purpose of the Study
This research study explored the cognitive and emotional apprehensions that
discourage participation in colorectal cancer screening tests despite patient education,
availability of health insurance, and physician recommendation.
Research Questions
This study addressed the following research questions:
1. Are cognitive and emotional apprehensions significant barriers to colorectal
cancer screening?
2. What are the particular cognitive and emotional barriers that inhibit
participation in colorectal cancer screening tests?
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3. How can cognitive and emotional barriers to colorectal cancer screening be
alleviated?
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Chapter II: Literature Review
Current literature points to colorectal cancer screening barriers related to patient
education, access to healthcare, physician counseling, and cognitive-emotional
apprehensions.
Patient Education
Knowledge of colorectal cancer is one of the key predictors of patient screening.
Studies indicate that never-screened patients have poor knowledge of cancer warning
signs, symptoms, and risk factors and less understanding of colorectal cancer incidence
and treatment outcomes (Harewood, Wiersema, & Melton, 2003; Shokar, Vernon, &
Weller, 2005). For example, Harewood et al. (2003) report that never-screened patients
significantly underestimate the risk to an average 60-year-old person developing colon
cancer and are more likely to underestimate the success of treatment for early stage colon
cancer when compared to estimates from previously screened patients. Thus, patients
with poor knowledge of colorectal cancer are less likely to participate in screening
procedures.
A lack of screening awareness can also hinder patient participation in colorectal
cancer surveillance. Patients who do not understand the concept of screening, who lack
knowledge of screening tests, or who lack awareness of the need for screening are less
likely to adhere to surveillance guidelines (Wee, McCarthy, & Phillips, 2004; Shokar et
al., 2005; Klabunde, Schenck, & Davis, 2006). Shoker et al. (2005) report that a
significant number of study participants “did not comprehend the purpose of screening
for cancer, were not able to distinguish screening tests from any other kind of test, and
did not realize that screening is preformed when a person feels well” (p. 345). Similarly,
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Wee et al. (2005) specify that the majority of respondents who failed to participate in
screening tests report their primary reason as being unaware of the need for screening.
Thus, screening awareness greatly influences colorectal cancer surveillance rates.
Access to Healthcare
Access to healthcare coverage is an additional predictor of colorectal cancer
surveillance. Studies show that lack of health insurance and financial resources are
significant barriers to screening in the United States (Denberg, Melhado, Coombes,
Beaty, Berman, Byers, Marcus, Steiner, & Ahnen, 2005; Kabunde, Vernon, Nadel,
Breen, Seeff, & Brown, 2005; Tabbarah, Nowalk, Raymund, Jewell, & Zimmerman,
2005). Denberg et al. (2005) report that particular health plans predict low adherence to
screening and that patients cite cost as a common logistical obstacle. Similarly, Tabbarah
et al. (2005) note that 19% of African American participants in their study choose not to
participate in screening tests because of cost. Financial limitations, therefore, restrict
patient access to screening tests and discourage adherence to colorectal cancer screening
guidelines.
Similar to patients who lack healthcare coverage, screening also tends to be low
among patients who lack a usual source of healthcare. Patients never screened for
colorectal cancer are less likely to have a regular primary physician (Harewood et al.,
2002). Moreover, patients who visit their physicians infrequently are less likely to report
colorectal cancer screening than patients who visit their physicians more frequently
(Tabbarah et al., 2005). Thus, patients who receive infrequent medical attention are less
likely to participate in colorectal cancer screening tests. A lack of regular healthcare,
then, discourages compliance with screening.
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Physician Counseling
Physician counseling is one of the prime determinants of colorectal cancer
screening. Patients are not likely to participate in colorectal cancer screening tests
without a recommendation from their physician (Klabunde et al., 2005; Wee et al., 2005;
Harewood et al., 2005; Wang, Liang, Chen, Cullen, Feng, Yi, Schwartz, & Mandelblatt,
2006; Klabunde et al., 2006; Teng, Friedman, & Green, 2006). Klabunde et al. (2005)
report that patients who visited a doctor in the past year or had health insurance were
more likely to report lack of physician recommendation as the main reason for not
participating in screening tests. Similarly, Wang and colleagues (2006) report that
women receiving recommendations for colon cancer screening have more than three-fold
increased odds of participating in screening tests than those who do not receive
recommendations. Thus, inadequate physician counseling has a significant impact on
colorectal cancer screening rates; without physician recommendations, patients are not
likely to pursue screening tests.
Patient perception of physician support may also be associated with colorectal
cancer screening rates. Patients are more likely to participate in colon cancer screening if
they believe their physicians support the tests. In 2005, Tabbarah and colleagues found
that patients who believed their doctor thought that they should be tested for colon cancer
were 19 times more likely to report a colonoscopy than patients without the belief. Thus,
perceptions of physician support appear to influence screening rates.
Cognitive and Emotional Barriers
In addition to perceptions of physician support, current literature suggests that
other cognitive and emotional apprehensions may act as barriers to colorectal cancer
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screening. Studies show that patients commonly express fear of pain or discomfort, fear
of the test preparation, and concerns about modesty or embarrassment as reasons for
avoiding participation in screening tests (Harewood et al., 2002; Walsh, Kaplan,
Nguyen, Gildengorin, McPhee, & Perez-Stable, 2004; Denberg et al., 2005). Similarly,
Greiner, Born, Nollen, & Ahluwalia (2005) report that fear is one of the most commonly
stated barriers to screening with fatalism and mistrust. Cognitive and emotional factors,
then, are likely to be significant barriers to colorectal cancer screening in spite of patient
education, healthcare access, and physician recommendation.
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Chapter III: Research Methodology
Sample Selection
The target population for this study consisted of adults at average or greater than
average risk for developing colorectal cancer who have received physician counseling
regarding colorectal cancer screening tests. As a result, participants were required to (1)
be 50 years of age or older, (2) have any type of healthcare coverage, and (3) have had a
physician recommend that they be screened for colorectal cancer in the past. Participants
under the age of 50 years who did not have healthcare coverage or who had not received
a physician recommendation to undergo colorectal cancer surveillance were excluded
from the study.
Human Subjects Protection
Prior to initiating this research, the Investigator submitted a Request for Approval
of Research Involving Human Subjects to the Eastern Michigan University College of
Health and Human Services Human Subjects Review Committee (HSRC) for review and
approval. The HSRC approved the study for initiation on February 12, 2008. Refer to
Appendix A for a copy of the HSRC Approval Letter.
All potential study participants were informed of the study purpose and
procedures by means of informed consent. The informed consent form indicated that
participation in this study was voluntary. All potential participants had the right to refuse
participation or withdraw from the study prior to mailing in the survey. They also had
the right to omit any survey question. As the form indicated, by completing and
returning the surveys, participants were providing their consent to join the study. Please
refer to Appendix B for the Implied Informed Consent Form.
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In addition, all data collected for this study were anonymous and confidential.
Participants were instructed via the implied informed consent form and the survey
directions not to sign their names to any of the forms or study questionnaires. There was
no record linking the subjects and the research.
Data Collection
Subsequent to HSRC approval, the Investigator distributed study information to
Eastern Michigan University (EMU) faculty via mail. Approximately 150 unselected
adults received the study packet and were asked to consider participating in the research
study. The study packet included the informed consent form, colorectal cancer screening
survey, and a self-addressed stamped envelope. Upon completion of the survey, the
informed consent form instructed participants to return the research information to the
Investigator via postal mail in the provided envelope. Refer to Appendix C for the
Colorectal Cancer Screening Survey used in this study.
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Chapter IV: Presentation and Analysis of Data
Demographic Data
The Investigator delivered 150 surveys to potential participants for this study.
Forty-seven participants returned surveys to the study team, which equates to a 31.3%
response rate. Seven participants did not meet the eligibility criteria; as a result, their
data were excluded from analysis. Thus, a final sample of 40 EMU faculty members
participated in this study.
Among the eligible participants, 24 adults reported prior participation in
colorectal cancer screening tests. The majority of these participants were 50 to 59 years
old (66.7%) with the other participants being 60 to 69 years old (33.3%). Twenty
participants were female (83.3%) and 4 participants were male (16.7%). In terms of
ethnicity, 22 of the participants were Caucasian (91.7%) and 2 of the participants were
African American (8.3%).
There were 16 adults, the non-screeners, who reported that they had not been
screened for colon or rectal cancer in the past. Fourteen of these participants were 50 to
59 years old (87.5%) and 2 participants were 60 to 69 years old (12.5%). Twelve
participants were female (75%) and 4 participants were male (25%). In terms of
ethnicity, all 16 participants were Caucasian. See Table 1 for detailed demographic data
of the study sample.
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Table 1
Demographic Characteristics of Study Sample (N =40)
Variable

Non-Screeners (n =16)

Screeners (n =24)

Gender
Male (20.0%)

4 (25.0%)

4 (16.7%)

12 (75.0%)

20 (83.3%)

50 to 59 (75.0%)

14 (87.5%)

16 (66.7%)

60 to 69 (25.0%)

2 (12.5%)

8 (33.3%)

70+ (0.0%)

0 (0.0%)

0 (0.0%)

African American (5.0%)

0 (0.0%)

2 (8.3%)

Asian (0.0%)

0 (0.0%)

0 (0.0%)

16 (100.0%)

22 (91.7%)

Some college (0.0%)

0 (0.0%)

0 (0.0%)

College graduate (20.0%)

8 (50.0%)

0 (0.0%)

Graduate school (80.0%)

8 (50.0%)

24 (100.0%)

Excellent (60.0%)

8 (50.0%)

16 (66.7%)

Good (37.5%)

7 (43.7%)

8 (33.3%)

Fair (2.5%)

1 (6.3%)

0 (0.0%)

Poor (0.0%)

0 (0.0%)

0 (0.0%)

Female (80.0%)
Age category (y)

Race

Caucasian (95.0%)
Education Level

Heath Status
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Research Question #1
The first objective of this research was to evaluate whether cognitive and
emotional opinions were significant barriers to colorectal cancer surveillance. Among
the non-screeners, the most common barriers to screening reported were cognitiveemotional apprehensions and logistical obstacles. Specifically, 50% of non-screeners
named personal feelings as the primary reason for not participating in colorectal cancer
screening tests. Logistical issues were named as the primary reason by 37.5% of nonscreeners, citing cost, time away from work, and transportation problems as specific
reasons for noncompliance (Table 2). As the primary reason for noncompliance, no
participants reported lack of knowledge about screening or feelings that screening tests
are unnecessary.
Research Question #2
The second objective of this research was to explore the specific cognitive and
emotional barriers that inhibit participation in colorectal cancer screening tests.
According to the results, non-screeners commonly expressed embarrassment, fear of
discomfort, concerns regarding the test preparation, and fear of finding cancer as
cognitive-emotional reasons for screening noncompliance. Non-screeners did not report
fatalism or feelings of mistrust. In addition, non-screeners did not report a lack of
physician support toward screening.
Participants commonly reported concerns about embarrassment or modesty as
cognitive-emotional barriers to colorectal cancer surveillance. As an explanation for
noncompliance, 50% of non-screeners reported that colorectal cancer screening tests are
embarrassing (Table 2). Furthermore, 62.5% of non-screeners reported that they would
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be more willing to be screened for colon cancer if they were less modest, compared to
8.3% of screeners (Table 3). All participants who reported concerns about modesty or
embarrassment were female.
In addition to apprehensions about embarrassment and modesty, participants
commonly reported themes of fear as barriers to colorectal cancer screening. Seventyfive percent of non-screeners reported fear of discomfort or concerns regarding the test
preparation as reasons for noncompliance with screening guidelines. Moreover, 25% of
non-screeners expressed that fear of finding cancer limited their participation in screening
tests (Table 2). Both male and female participants reported fear as a common barrier.
Participants in this study did not report fatalistic beliefs, feelings of mistrust, or
lack of physician support as barriers to colorectal cancer surveillance. No participants
felt that cancer is inevitable, and all non-screeners agreed that if colon cancer was
detected early by tests, it could likely be cured. All participants agreed to some extent
that they trusted screening tests to be thorough and accurate, and approximately 88% of
non-screeners and 92% of screeners agreed that their physician supports their
participation in colorectal cancer screening tests (Table 3).
Research Question #3
The third objective of this research was to explore how physicians or public
campaigns could potentially alleviate cognitive and emotional apprehensions to
colorectal cancer screening. According to the results, 62.5% of non-screeners reported
that they would be more willing to be screened for colorectal cancer if they were able to
choose the gender of the physician performing the test; only 8.3% of screeners shared this
opinion (Table 3). In addition, one-half of non-screeners reported that they would be

14

more willing to undergo a colonoscopy if they could be sedated during the test, and all
non-screeners reported that they would be more willing to participate in screening tests if
the examination consisted of a blood test only.

15

Table 2
Barriers to Colorectal Cancer Screening Reported by Non-Screeners
Barrier

Total (n =16)

CRC Knowledge
Not at risk for CRC

4 (25.0%)

No symptoms

4 (25.0%)

Cognitive-emotional barriers
Fatalism

0 (0.0%)

Embarrassment

8 (50.0%)

Fear of test preparation

6 (37.5%)

Fear of pain or discomfort

6 (37.5%)

Fear of finding cancer

4 (25.0%)

Logistical obstacles
Busy

0 (0.0%)

Time away from work

8 (50.0%)

Transportation problems

4 (25.0%)

Cost

4 (25.0%)
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Table 3
Colorectal Cancer Screening Attitudes Reported by Study Participants
Attitude

Non-Screeners

Screeners

Total

(n =16) (%)

(n =24) (%)

(n =40) (%)

Trust that CRC screening tests
are thorough and accurate

100.0

100.0

100.0

Believe their physician
supports CRC screening

87.5

91.7

90.0

Believe if CRC was detected
early by tests, it could be cured

100.0

91.7

95.0

More likely to participate if
able to choose the gender of
the physician

62.5

8.3

30.0

More likely to participate in
colonoscopy if sedated

50.0

83.3

70.0

More likely to participate in a
blood test

100.0

41.7

65.0

More likely to participate if
less modest

62.5

8.3

30.0
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Chapter V: Discussion
Based on the survey results, the investigator identified several cognitive and
emotional apprehensions that discourage participation in colorectal cancer surveillance,
including patient concerns about embarrassment and modesty, concerns about the
unpleasantness of the test preparation, fear of discomfort associated with the screening
procedures, and fear of finding cancer. These apprehensions existed despite education,
the availability of health insurance, and physician recommendations for screening.
Non-screeners reported concerns about embarrassment and modesty as the most
common cognitive-emotional barriers to colorectal cancer surveillance. Although the
sample did not include a large number of men, it is interesting to note that all participants
who reported these concerns were female. Cultural perceptions of body image may
promote these types of feelings in women and discourage adherence to screening tests.
The results show that allowing patients to choose the gender of the physician performing
the test may help decrease these apprehensions and increase initial screening rates. Since
most screeners did not report a gender preference or feelings of modesty, concerns about
embarrassment should significantly decrease after participation.
In addition to concerns about embarrassment and modesty, non-screeners also
reported themes of fear as barriers to screening, including fear of pain or discomfort
associated with colonoscopy. Since non-screeners reported that they would be more
willing to participate in screening tests if they could be sedated or if the examination
consisted of only a blood test, it appears that fears may relate to the invasive nature of the
test. Thus, it is evident that these apprehensions deserve greater attention in patient
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counseling and education efforts. Physicians may also wish to promote the alternatives to
colonoscopy for these select patients.
One-fourth of non-screeners also reported fear of finding cancer as a barrier to
screening. Even though all participants agreed that getting a colon cancer test is a wise
thing to do, a cancer diagnosis could expose patients to a variety of emotions and burdens
that some people may not be prepared to manage. It would be interesting for future
studies to research this specific apprehension further to isolate the particular fears of
diagnosis (e.g. concerns about recovery, cost of treatment, and/or time involved with
treatment).
In contrast to earlier studies, fatalistic beliefs, feelings of mistrust, and perceptions
of physician support were not predictors of screening adherence. This may be due to the
small sample size or the lack of representation of different minority or socioeconomic
populations. These concerns may also not be relevant to this sample of participants, as
the majority were highly educated professionals. It is interesting to note, however, that
nearly all participants agreed that their physician supports participation in colorectal
cancer screening tests. Thus, rather than physician counseling, the non-screeners within
this community may need an additional type of intervention to promote screening
adherence.

19

Chapter VI: Conclusions
Implications for Clinical Practice and Public Campaign
This study showed that cognitive and emotional apprehensions are significant
barriers to colorectal cancer surveillance. Cognitive-emotional predictors of adherence
included concerns about embarrassment and modesty, concerns about the unpleasantness
of test preparation, fear of pain or discomfort associated with the screening procedures,
and fear of finding cancer. It is therefore imperative that future interventions focus on
means to overcome these cognitive-emotional barriers and increase screening rates.
Future interventions to overcome cognitive-emotional apprehensions may allow
clinics to cater to patient preferences or include public campaigns that promote additional
education. Patient concerns regarding embarrassment or modesty may be alleviated by
allowing patients to choose the gender of the physician performing the screening tests.
Physician counseling and patient education efforts may also help decrease concerns about
colonoscopy or the test preparation. Ultimately, a comprehensive approach should be
developed to address the multiple barriers that influence participation in colorectal cancer
screening tests.
Limitations of the Study
The investigator carried out this study within a single academic institution using a
convenience sample of faculty members. The sample size used in this study was
relatively small, and male and minority populations were not well represented.
Nonetheless, the investigator suspects the themes of embarrassment and fear observed in
this study to be applicable to other populations in other areas of the country.

20

Recommendations for Further Research
To confirm the results of this study, future investigators should replicate this
research in a larger patient population using a random sample of study participants. The
investigators should ensure that male participants and minority populations are included
in future studies since they were not well represented in this research. It may also be
interesting for future studies to highlight distinct cultures and examine if cognitiveemotional apprehensions influence colorectal cancer screening rates in the populations
differently.
Since women in this study were more likely to report concerns about
embarrassment and modesty, future studies may wish to focus on the cognitive-emotional
apprehensions that differ between genders. There may be other important cognitiveemotional barriers to colorectal cancer screening that affect men and women differently.
Future interventions can then tailor messages to different members of the community.
This research did not collect demographic data relating to participant marital
status. It would be interesting for future studies to examine how martial status influences
colorectal cancer screening rates in the general population. It would also be interesting to
examine how a patient’s perception of support for screening by a spouse or significant
other compares to perceptions of support by a physician. Personal relationships may
serve as an additional barrier to colorectal cancer screening.
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